Gilead Sciences, Inc. (NASDAQ:GILD) Q3 2023 Earnings Conference Call November 7, 2023 4:30 PM ET
Company Participants
Jacquie Ross - Vice President, Investor Relations
Daniel O'Day - Chairman and Chief Executive Officer
Johanna Mercier - Chief Commercial Officer
Merdad Parsey - Chief Medical Officer
Andrew Dickinson - Chief Financial Officer
Cindy Perettie - Executive Vice President, Kite
Conference Call Participants
Geoff Meacham - Bank of America
Michael Yee - Jefferies
Daina Graybosch - Leerink Partners
Chris Schott - JPMorgan
Salveen Richter - Goldman Sachs
Tyler Van Buren - TD Cowen
Brian Abrahams - RBC Capital Markets
Terrence Flynn - Morgan Stanley
Evan Seigerman - BMO Capital Markets
Joe Catanzaro - Piper Sandler
Operator
Hello everyone and welcome to the Third Quarter 2023 Gilead Sciences' Earnings Conference Call. My name is Nadia and I'll be coordinating the call today. [Operator Instructions]
I will now hand over to your host, Jacquie Ross, Vice President of Investor Relations to begin. Jacquie please go ahead.
Jacquie Ross
Thank you and good afternoon everyone. Just after market close today, we issued a press release with earnings results for the third quarter of 2023. The press release, slides, and supplementary data are available on the Investors section of our website at gilead.com.
The speakers on today's call will be our Chairman and Chief Executive Officer, Daniel O'Day; our Chief Commercial Officer, Johanna Mercier; our Chief Medical Officer, Merdad Parsey; and our Chief Financial Officer, Andrew Dickinson. After that, we'll open the call to Q&A, where the team will be joined by Cindy Perettie, the Executive Vice President of Kite.
Before we get started, let me remind you that we will be making forward-looking statements, including those related to Gilead's business, financial condition, and results of operations, plans and expectations with respect to products, product candidates, corporate strategy, business and operations, financial projections and the use of capital, and 2023 financial guidance, all of which involve certain assumptions, risks, and uncertainties that are beyond our control and could cause actual results to differ materially from these statements.
A description of these risks can be found in the earnings press release and our latest SEC disclosure documents. All forward-looking statements are based on information currently available to Gilead and Gilead assumes no obligation to update any such forward-looking statements.
Non-GAAP financial measures will be used to help you understand the Company's underlying business performance. The GAAP to non-GAAP reconciliations are provided in the earnings press release, in our supplemental data sheet, as well as on the Gilead website.